Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2000
12/21/2000WO2000077034A2 Amino acids from fish and soy proteins improve insulin sensitivity
12/21/2000WO2000077022A1 50 human secreted proteins
12/21/2000WO2000077021A1 48 human secreted proteins
12/21/2000WO2000077018A2 Purine derivatives
12/21/2000WO2000077016A1 DERIVATIVES OF 4'-DEMYCAROSYL-8a-AZA-8a-HOMOTYLOSIN
12/21/2000WO2000077011A1 Organosilyl compounds having nuclear hormone receptor modulating activity
12/21/2000WO2000077010A2 Substituted heterocycle fused gamma-carbolines
12/21/2000WO2000077009A1 DITHIEPINO[6,5-b]PYRIDINES, AND RELATED COMPOSITIONS AND METHODS
12/21/2000WO2000077004A1 1-azatricyclic-4-benzylpiperazines
12/21/2000WO2000077003A1 Optically active pyrrolopyridazine compounds
12/21/2000WO2000077002A1 Substituted heterocycle fused gamma-carbolines
12/21/2000WO2000077001A1 Substituted heterocycle fused gamma-carbolines
12/21/2000WO2000077000A1 New bispidine compounds useful in the treatment of cardiac arrhythmias
12/21/2000WO2000076999A1 New bispidine compounds useful in the treatment of cardiac arrhythmias
12/21/2000WO2000076998A1 New bispidine compounds useful in the treatment of cardiac arrhythmias
12/21/2000WO2000076997A1 New bispidine compounds useful in the treatment of cardiac arrhythmias
12/21/2000WO2000076988A1 Rhodanine derivatives and their use in inhibiting and imaging amyloids
12/21/2000WO2000076987A1 Rhodanine derivatives for use in a method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/21/2000WO2000076984A2 Novel compounds, their use and preparation
12/21/2000WO2000076982A1 Antagonism of immunostimulatory cpg-oligonucleotides by 4-aminoquinolines and other weak bases
12/21/2000WO2000076972A1 N-cyclopentyl modulators of chemokine receptor activity
12/21/2000WO2000076971A2 Serine protease inhibitors
12/21/2000WO2000076969A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives
12/21/2000WO2000076962A1 Thiol derivative, metallo-beta-lactamase inhibitors
12/21/2000WO2000076961A1 Inhibitors of aspartyl protease
12/21/2000WO2000076958A2 Mono- and disubstituted 3-propyl gamma-aminobutyric acids
12/21/2000WO2000076956A2 Enantiomers of n-desmethyl venlafaxine
12/21/2000WO2000076955A1 Enantiomers of o-desmethyl venlafaxine
12/21/2000WO2000076953A1 Benzene derivatives, preparation method and pharmaceutical compositions containing same
12/21/2000WO2000076556A2 High dose radionuclide complexes for bone marrow suppression
12/21/2000WO2000076554A1 Ligand-conjugated oligomeric compounds
12/21/2000WO2000076553A1 Use of viral vectors and charged molecules for gene therapy
12/21/2000WO2000076552A1 Methods and compositions for control of bone formation via modulation of leptin activity
12/21/2000WO2000076551A2 Method for producing an injectable medicament preparation
12/21/2000WO2000076549A1 Liquid pharmaceutical composition for oral administration of bitter hydrolysis-susceptible active substances
12/21/2000WO2000076547A1 Stabilized vitamin c formulations
12/21/2000WO2000076545A1 Anaesthetic formulation comprising an nmda-antagonist and an alpha-2 adrenergic agonist
12/21/2000WO2000076544A1 Aminotetralin derivative for the therapy of cardiovascular diseases
12/21/2000WO2000076543A1 Ocular tension lowering composition for topical adminstration
12/21/2000WO2000076535A1 Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c)
12/21/2000WO2000076530A1 49 human secreted proteins
12/21/2000WO2000076529A2 Use of estrogen receptor agonists or antagonists for treating growth, bone disorders
12/21/2000WO2000076526A1 Method for the prevention and treatment of chronic venous insufficiency
12/21/2000WO2000076523A1 Methods for modulating fxr receptor activity
12/21/2000WO2000076522A1 Administration of non-oral androgenic steroids to women
12/21/2000WO2000076521A1 Antiviral indoleoxoacetyl piperazine derivatives
12/21/2000WO2000076520A1 Antifungal oral composition containing itraconazole and process for preparing same
12/21/2000WO2000076519A1 Sulfonamide and sulfamide substituted imidazoquinolines
12/21/2000WO2000076518A1 Urea substituted imidazoquinolines
12/21/2000WO2000076517A1 Il-8 receptor antagonists
12/21/2000WO2000076516A1 Il-8 receptor antagonists
12/21/2000WO2000076515A1 Il-8 receptor antagonists
12/21/2000WO2000076510A1 Dermal anesthetic agents
12/21/2000WO2000076509A1 Nasal delivery of apomorphine
12/21/2000WO2000076508A1 Il-8 receptor antagonists
12/21/2000WO2000076507A1 Method for increasing the solubility of morphine and pharmaceutical compositions prepared therefrom
12/21/2000WO2000076506A1 Pharmaceutical formulations and methods comprising intranasal morphine
12/21/2000WO2000076505A1 Amide substituted imidazoquinolines
12/21/2000WO2000076504A1 Production of agglomerates of inogatran and the compound inogatran anhydrate
12/21/2000WO2000076503A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000WO2000076502A1 Methods and compositions for treating raynaud's phenomenon and scleroderma
12/21/2000WO2000076501A1 Il-8 receptor antagonists
12/21/2000WO2000076500A2 Compound for use as a medicament for treatment of disorders involving bronchocontraction
12/21/2000WO2000076499A2 Neuroprotective and retinoprotective ophthalmologic medicines
12/21/2000WO2000076498A1 PHARMACEUTICAL COMPOSITIONS CONTAINING 8-CHLORO-3(β-DIETHYLAMINOETHYL)-4-METHYL-7-ETHOXYCARBONYL-METHOXY COUMARIN BASE AND THE SALTS THEREOF, WITH CHOLESTEROL-LOWERING ACTIVITY
12/21/2000WO2000076497A1 Cancer therapy
12/21/2000WO2000076496A1 Tumor tissue accumulation enhancers for drugs
12/21/2000WO2000076495A1 Il-8 receptor antagonists
12/21/2000WO2000076493A1 Combination therapy for effecting weight loss and treating obesity
12/21/2000WO2000076491A1 Utilization of a highly fluorinated oligomeric alkan in ophthalmology
12/21/2000WO2000076490A2 Methods and compositions for treating urinary frequency and urgency using optically pure (s)-oxybutynin
12/21/2000WO2000076489A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/21/2000WO2000076488A2 Use of a ppar agonist for treating type 1 diabetes
12/21/2000WO2000076487A2 Use of paclitaxel and steriod derivatives as aromatase inhibitors for the treatment of cancer
12/21/2000WO2000076485A1 Moisture-sensitive preparation of percutaneous absorption type
12/21/2000WO2000076484A1 Pharmaceutical preparation with delayed release of an active substance
12/21/2000WO2000076482A1 Novel formulations comprising lipid-regulating agents
12/21/2000WO2000076481A1 Mesalazine controlled release oral pharmaceutical compositions
12/21/2000WO2000076478A1 Controlled release and taste masking oral pharmaceutical compositions
12/21/2000WO2000076477A1 Methods and compositions for treating breakthrough pain
12/21/2000WO2000076475A1 Prophylactic, therapeutic and industrial antioxidant compositions enhanced with stabilized atomic hydrogen/free electrons and methods to prepare and use such compositions
12/21/2000WO2000076474A1 Acidic buffered nasal spray
12/21/2000WO2000076472A1 Anhydrous antiperspirant cream compositions having improved perfume longevity
12/21/2000WO2000076470A1 Synergistic antibacterial combination
12/21/2000WO2000076464A2 Oxidatively stable, long-chain ethyl ester emollients
12/21/2000WO2000076457A2 Il-8 receptor antagonists
12/21/2000WO2000076454A2 Therapeutic compositions for ophthalmic use and therapeutic compositions for brain central lesions
12/21/2000WO2000076452A2 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative
12/21/2000WO2000076451A2 Pharmaceutical composition comprising no or at least a no donor compound inducing no formation in cells
12/21/2000WO2000076318A1 Nitric oxide donors for inducing neurogenesis
12/21/2000WO2000076316A1 Methods related to metabolism of parasites and mycobacteria
12/21/2000WO2000076315A1 Transdermally delivered aspirin
12/21/2000WO2000076314A1 Compositions and methods comprising morphine gluconate
12/21/2000WO2000056404B1 Formulations for treatment of pain comprising vitamin b12 and phenylanine
12/21/2000WO2000054747A3 Method for treating dry eye
12/21/2000WO2000053581A3 Heterocyclic compounds having antitumor activity
12/21/2000WO2000053166A3 Use of condensed 2,3-benzodiazepine derivatives for the treatment and prophylaxis of diseases related to the inhibition of lipid peroxidation
12/21/2000WO2000051587A3 Jak-3 inhibitors for treating allergic disorders
12/21/2000WO2000050062A3 Methods and compositions for altering mucus secretion
12/21/2000WO2000050047A3 Composition for the treatment of psoriasis
1 ... 6188 6189 6190 6191 6192 6193 6194 6195 6196 6197 6198 6199 6200 6201 6202 6203 6204 6205 6206 6207 6208 ... 7860